Explore how pharmacists are leading the way in precision transplant care through pharmacogenomics. This session highlights CYP enzyme polymorphisms, their impact on drug metabolism, and how genomic insights can prevent treatment failure. Discover practical strategies to integrate pharmacogenomic screening into clinical workflows and elevate transplant outcomes.

This presentation will address the following learning objectives:

• Describe the role of pharmacogenomics in transplant medicine, with a focus on CYP enzyme polymorphisms and their impact on drug metabolism
• Interpret key pharmacogenomic study findings that identify patients at risk of treatment failure due to genetic variability
• Evaluate how pharmacist-led pharmacogenomic interventions can optimise immunosuppressant therapy and improve transplant outcomes
• Explain how pharmacogenomic testing can be integrated into clinical workflows in transplant settings
• Advocate for the pharmacist’s role in advancing precision medicine through genomic innovation